These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 22117632)

  • 1. Pathogenesis of autoimmune hepatitis.
    Liberal R; Longhi MS; Mieli-Vergani G; Vergani D
    Best Pract Res Clin Gastroenterol; 2011 Dec; 25(6):653-64. PubMed ID: 22117632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aetiopathogenesis of autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aetiopathogenesis of autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive immunity in autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutting edge issues in autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Clin Rev Allergy Immunol; 2012 Jun; 42(3):309-21. PubMed ID: 21207191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and regulation of autoreactive CD8+ T cells in a transgenic mouse model of autoimmune hepatitis.
    Zierden M; Kühnen E; Odenthal M; Dienes HP
    Gastroenterology; 2010 Sep; 139(3):975-86, 986.e1-3. PubMed ID: 20639127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiopathogenesis of autoimmune hepatitis.
    Floreani A; Restrepo-Jiménez P; Secchi MF; De Martin S; Leung PSC; Krawitt E; Bowlus CL; Gershwin ME; Anaya JM
    J Autoimmun; 2018 Dec; 95():133-143. PubMed ID: 30385083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis.
    Longhi MS; Zhang L; Mieli-Vergani G; Vergani D
    Autoimmun Rev; 2024; 23(7-8):103591. PubMed ID: 39117005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-regs in autoimmune hepatitis-systemic lupus erythematosus/mixed connective tissue disease overlap syndrome are functionally defective and display a Th1 cytokine profile.
    Longhi MS; Ma Y; Grant CR; Samyn M; Gordon P; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Mar; 41():146-51. PubMed ID: 23287048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune hepatitis: a comprehensive review.
    Liberal R; Grant CR; Mieli-Vergani G; Vergani D
    J Autoimmun; 2013 Mar; 41():126-39. PubMed ID: 23218932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of autoimmune hepatitis.
    Vergani D; Choudhuri K; Bogdanos DP; Mieli-Vergani G
    Clin Liver Dis; 2002 Aug; 6(3):727-37. PubMed ID: 12362577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantigen-specific regulatory T cells, a potential tool for immune-tolerance reconstitution in type-2 autoimmune hepatitis.
    Longhi MS; Hussain MJ; Kwok WW; Mieli-Vergani G; Ma Y; Vergani D
    Hepatology; 2011 Feb; 53(2):536-47. PubMed ID: 21274874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interplay between regulatory and effector T cells in autoimmune hepatitis: Implications for innovative treatment strategies.
    Muratori L; Longhi MS
    J Autoimmun; 2013 Oct; 46():74-80. PubMed ID: 23871639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mimicry rather than identity breaks T-cell tolerance in the CYP2D6 mouse model for human autoimmune hepatitis.
    Ehser J; Holdener M; Christen S; Bayer M; Pfeilschifter JM; Hintermann E; Bogdanos D; Christen U
    J Autoimmun; 2013 May; 42():39-49. PubMed ID: 23200317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
    Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function.
    Ai G; Yan W; Yu H; Xiao F; Xi D; Ma K; Huang J; Luo X; Wan X; Ning Q
    J Gene Med; 2018 Jul; 20(7-8):e3023. PubMed ID: 29756667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Pediatr Transplant; 2004 Dec; 8(6):589-93. PubMed ID: 15598331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T helper cells plasticity in inflammation.
    Cosmi L; Maggi L; Santarlasci V; Liotta F; Annunziato F
    Cytometry A; 2014 Jan; 85(1):36-42. PubMed ID: 24009159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effector T helper cell triade.
    Fietta P; Delsante G
    Riv Biol; 2009; 102(1):61-74. PubMed ID: 19718623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
    Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.